Search research articles
Contact Us
Filters
Showing results (101-110 of 106) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 106 results.
JCI Insight
|
July 12, 2019
Changes in plasma lipids predict pravastatin efficacy in secondary prevention
Kaushala S Jayawardana, Piyushkumar A Mundra, Corey Giles, et al.
Heart, Lung & Circulation
|
September 3, 2020
Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry
Jing Pang, David R Sullivan, David L Hare, et al.
Circulation
|
August 23, 2013
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis
S Matthijs Boekholdt, Benoit J Arsenault, G Kees Hovingh, et al.
Ebiomedicine
|
October 17, 2021
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase
Hui-Ming Lin, Blossom Mak, Nicole Yeung, et al.
Atherosclerosis. Supplements
|
September 16, 2011
Familial hypercholesterolaemia: a model of care for Australasia
Gerald F Watts, David R Sullivan, Nicola Poplawski, et al.
Journal of the American College of Cardiology
|
September 20, 2023
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review
Gemma A Figtree, Stephen T Vernon, Jason A Harmer, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 106) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 106 results.
JCI Insight
|
July 12, 2019
Changes in plasma lipids predict pravastatin efficacy in secondary prevention
Kaushala S Jayawardana, Piyushkumar A Mundra, Corey Giles, et al.
Heart, Lung & Circulation
|
September 3, 2020
Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry
Jing Pang, David R Sullivan, David L Hare, et al.
Circulation
|
August 23, 2013
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis
S Matthijs Boekholdt, Benoit J Arsenault, G Kees Hovingh, et al.
Ebiomedicine
|
October 17, 2021
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase
Hui-Ming Lin, Blossom Mak, Nicole Yeung, et al.
Atherosclerosis. Supplements
|
September 16, 2011
Familial hypercholesterolaemia: a model of care for Australasia
Gerald F Watts, David R Sullivan, Nicola Poplawski, et al.
Journal of the American College of Cardiology
|
September 20, 2023
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review
Gemma A Figtree, Stephen T Vernon, Jason A Harmer, et al.
Page
of 11